Are Victoria Oil & Gas plc, Mothercare plc And Angle plc A Buy After Today’s News?

Roland Head assesses today’s updates from Victoria Oil & Gas plc (LON:VOG), Mothercare plc (LON:MTC) and ANGLE plc (LON:AGL).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Three popular private investor stocks, Victoria Oil & Gas (LSE: VOG), Mothercare (LSE: MTC) and Angle (LSE: AGL), each issued trading updates this morning.

All three firms have seen their share prices move sharply since markets opened, so I’ve been taking a closer look at each company’s news.

Mothercare

Shares in Mothercare fell by 7% this morning after the firm reported a 5.2% decline in group sales.

Although UK like-for-like sales were up by 1.3% and online sales rose by 24%, total UK sales fell by 0.9%.

UK store space fell by 5.3% as loss-making stores were eliminated, but Mothercare chief executive Mark Newton-Jones said that careful stock management and reduced discounting is helping to improve profit margins.

However, the firm’s international expansion appears to have hit a speed bump. Despite a 7.9% increase in international retail space over the last 15 weeks, sales fell by 4.8% during the same period.

This is probably the major factor behind today’s drop. If Mothercare’s total sales are falling, then the firm’s wafer-thin profit margins and its forecast P/E of 28 look increasingly unappealing.

Mothercare remains a sell, for me.

Victoria Oil & Gas

Things seem to be improving at serial underperformer Victoria Oil & Gas.

The firm debuted a new format quarterly update today, highlighting a 178% rise in gas sales from its Logbaba field during the second quarter. Average gas production has risen from 4.5 million standard cubic feet per day (mmscf/d) during the first calendar quarter of the year to 12.6 mmscf/d during the second quarter.

I was also encouraged to see that cash received for gas sales rose by 92% to $9.8m during the last quarter.

Today’s update mentioned Victoria’s reassuring $14.2m cash balance, but did not refer to net debt, which was $6.6m at the end of November.

Unfortunately, there was no information on average gas sale prices, either. I suspect these have fallen over the last year.

The problem I have is that Victoria is very slow at publishing its accounts — last year’s results were published five months after the year ended. This makes it difficult to get an accurate picture of the firm’s finances.

Although Victoria is expected to report a profit this year and trades on a 2016 P/E of 5.5, I would wait for evidence of positive cash flow before buying.

Angle

Shares in small-cap medical tech company Angle fell to a low of 86p after markets opened this morning, before recovering to around 90p.

The firm, which is developing tests for cancer, published its preliminary results today. The highlights seemed positive, confirming that the firm will begin selling ovarian cancer test kits for research use this year.

In the meantime, the figures suggest that Angle should have enough cash to keep things moving for at least another year. In the year to 30 April, Angle reported cash outgoings of £3.8m, less than half the £8.4m cash balance reported at the end of last year.

So is Angle a buy? The company says that the ovarian cancer diagnostics market could be worth £300m per year, while the overall cancer diagnostic market could be worth £8bn per year.

These are big numbers, but Angle’s product has yet to prove its commercial appeal for even one type of cancer. The firm remains a speculative buy at best, in my view.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Roland Head has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Passive income text with pin graph chart on business table
Investing Articles

Yields of up to 7%! I’d consider boosting my income with these FTSE dividend stocks

The London market has some decent-looking dividend stocks right now, and I’m tempted by these two for growing income streams.

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

I’d put £20K in an ISA now to target a £1,900 monthly second income in future!

Christopher Ruane shares why he thinks a long-term approach to investing and careful selection of shares could help him build…

Read more »

Mature couple at the beach
Investing Articles

6 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Black woman using loudspeaker to be heard
Investing Articles

I was right about the Barclays share price! Here’s what I think happens next

Jon Smith explains why he still feels the Barclays share price is undervalued and flags up why updates on its…

Read more »

Investing Articles

Where I’d start investing £8,000 in April 2024

Writer Ben McPoland highlights two areas of the stock market that he would target if he were to start investing…

Read more »

View of Tower Bridge in Autumn
Investing Articles

Ahead of the ISA deadline, here are 3 FTSE 100 stocks I’d consider

Jon Smith notes down some FTSE 100 stocks in sectors ranging from property to retail that he thinks could offer…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Why I think Rolls-Royce shares will pay a dividend in 2024

Stephen Wright thinks Rolls-Royce shares are about to pay a dividend again. But he isn’t convinced this is something investors…

Read more »

Investing Articles

1 of the best UK shares to consider buying in April

Higher gold prices and a falling share price have put this FTSE 250 stock on Stephen Wright's list of UK…

Read more »